Pharma and Life Sciences Solutions
-
Hub Programs from the Patient Perspective
-
An Evolving Healthcare Ecosystem: Pharma’s Role in Solving SDoH and Health Equity Issues
-
Approaches for Better HCP Engagement
There is a growing demand in pharma for solutions that offer a data-driven approach to engage with healthcare providers in a scalable way. The end goal is to create a better end-to-end experience.
-
Digital Engagement in Pharma: Staying Ahead of Patient Needs to Shape Better Outcomes
For pharma to thrive, it must adapt to using technologies like text messages, emails and IVR in thoughtful new ways to automate and to simplify the approach to patient engagement.
-
Applying Predictive Analytics in Adherence Programs
It’s time for the pharmaceutical services industry to start widely applying predictive analytics — and introduce prescriptive analytics — to realize the significant benefits of improved adherence.
-
Innovations to Increase Healthcare Provider Access and Engagement
-
The Role of Hubs in Patient Adherence
-
The Evolution of Reimbursement and Access Services
-
Today's hub blueprint: Lock in on the journey
-
Hybrid hubs and today's patient-centric push
-
The Evolution of Pharma Sales: 4 Insights and Predictions
The pandemic permanently altered the pharmaceutical industry and required novel approaches to healthcare provider and patient engagement. Here are some ways that pharma sales will continue to evolve,
-
Drug Manufacturers Take A Fresh Look as PAPs Continue to Hold Spotlight
-
e-Book: 3 Data-Driven Strategies to Build a Connected Healthcare Ecosystem
-
Applying Next Best Action Technology in Pharmaceutical Services
-
Overcoming Payer Barriers through the Three Pillars of Hub Onboarding: Rate, Time, Duration
Pharmaceutical manufacturers and payers are often at odds over pricing and barriers to new medication access. Payers will typically initiate a variety of cost containment initiatives,
-
eBook: Mission Critical - Staying resilient together in the face of uncertainty
-
Transforming Pharma Field Sales Requires Digitally Empowered Teams
Big data has the ability to transform pharma field sales — if pharma manufacturers can translate data into actionable insights and real-time outreach at the individual territory level.
-
Patient-Focused Drug Development (PFDD) — the FDA Guidance that Changes How Life Sciences Works
The FDA is encouraging the industry to include patients in a meaningful way in drug development — from pre-IND through commercialization.
-
Loading More...